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Introduction
The World Health Organization (WHO) report in 2003 1) reviewed its conventional approach to evaluate patients' attitudes toward treatment based on "compliance" (to what extent patients follow physi-cians' instructions), and introduced the new concept of "adherence," in which patients understand and consent to the recommended treatment including diet, exercise, and drug therapy, and become proactively involved in treatment by taking medication correctly, improving their lifestyle, and so on. In response to this, many clinical studies using adherence measurements have been conducted in Western countries, where the importance of improving adherence is emphasized [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Improvement of lifestyle plays a central role in the prevention and treatment of arteriosclerosis. In LDL-C level and incidence of cardiovascular disease under treatment with pravastatin, and will be evaluated after finishing the follow-up.
Statistical Methods

Establishment of Domains and Adherence Scores
First, exploratory factor analysis (principal component analysis with oblique rotation was used as a factor extraction method) was conducted to determine the appropriateness of each of the 18 questions related to adherence in the questionnaire. Using eigenvalues and a scree plot obtained from principal component analysis, the number of potential factors that composed the questionnaire was determined. Factors with eigenvalues ＞1.0 and those above the elbow line in the scree plot were retained to determine the number of factors. Then, factor analysis of the results of the questionnaire was conducted to establish a potential domain structure. Those variables with factor loading ≥ 0.4 were judged to have contributed to a specific factor 16) . Exploratory factor analysis was conducted in advance in order to validate the appropriateness of the questionnaire items to be used for establishment of the adherence scores. Answer options for each question were evenly scored from 0 to 3 to indicate the worst to best adherence, and adherence scores were calculated by summing scores for each domain. These domain structures were validated on the basis of internal consistency of the domain using Spearman's rank correlation, and the appropriateness of adherence scores as a synthesized evaluation index was confirmed based on the item characteristic curve.
Relationship between Adherence Scores and Lipid Values
Patients who answered questionnaires at baseline or after 1 year, and whose lipid values were obtained during the treatment period were included in the analysis.
The relationship between adherence scores and LDL-C, HDL-C, and TG values during the 1-year treatment period was analyzed by each domain using single regression analysis and multiple regression analysis that included background factors for each lipid parameter as covariates, which were selected by the stepwise selection method (significance p = 0.10) from the following variables: sex, age, baseline HDL-C values, family history of coronary disease, hypertension, diabetes, and smoking. LDL-C values obtained by direct measurement and fasting TG values were used in the analysis.
Moreover, the relationship between the improveJapan, the importance of lifestyle modification is underlined in the "Guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese 2007" 12) , and the "National Health Promotion Movement in the 21st Century (Healthy Japan 21)" 13) , as well as the obligation to provide health guidance for patients with metabolic syndrome introduced by the Ministry of Health, Labour and Welfare. Nevertheless, despite the fact that long-term continuous treatment of dyslipidemia is important for prevention of arteriosclerosis 9, 14) , few studies have evaluated clinical outcomes from the viewpoint of adherence in Japan. Meanwhile, numerous reports have established the value of statin treatment, and many hypercholesterolemic patients have been treated with statins. Therefore, in the present study, we evaluated high-risk patients who were under treatment with pravastatin for primary prevention of coronary artery disease in order to determine the impact of adherence (patients' attitudes toward diet, exercise, and drug therapy) on on-treatment serum lipid control for a year, as the secondary objective of the APPROACH-J Study.
Methods
The details of the APPROACH-J Study have been described previously 15) . Briefly, of patients who were receiving or started receiving treatment with pravastatin, high-risk patients were selected according to the definition in the guidelines for the prevention of arteriosclerosis released in 2007 12) , that is, patients who have diabetes or at least 3 of the following conditions: elderly, hypertension, smoker, low high-density lipoprotein cholesterol (HDL-C) and/or high triglycerides (TG), and family history of ischemic heart disease. Patients were then followed for 2 years. During the follow-up period, the incidence of cardiovascular events, use of pravastatin, concomitant drugs, blood pressure, laboratory parameters including serum lipids [low-density lipoprotein cholesterol (LDL-C), HDL-C, and TG], and adverse events were recorded in a case report by study investigators. Moreover, questionnaire surveys comprising 21 questions, including 18 questions concerning awareness of health, and current status of diet, exercise, and drug therapy 16) , were conducted at baseline and after 1 year. The results of the last questionnaire were used for analysis.
The study adhered to Japanese regulations for post-marketing surveillance, and was conducted in accordance with the principles of the Declaration of Helsinki. All patients provided written informed consent. The primary objective of the APPROACH-J study is to determine the relationship between the after 1 year were not available (Fig. 1) .
In exploratory factor analysis, it was assumed that 5 factors were involved in the questionnaire including 18 questions related to adherence. Based on this assumption, loading of each factor was determined by exploratory factor analysis. As a result, it was found that Question 12, "How many days a week do you proactively take vitamins ?" had less consistency with other factors. In addition, patients had various impressions from the question, for instance, supplements, vegetables, or fruits; therefore, this question was excluded from the questionnaire. In addition, there were 2 overlapping questions concerning use of a pedometer (frequency and number of steps), so the question asking about the number of steps was selected for Question 17, since it reflects the degree of exercise. Question 21, "Do you know what pravastatin is used for ?" was also excluded because it is likely to be affected by the outcomes of compliance guidance given to patients, which makes it difficult to assess patients' awareness of health.
By excluding the above 3 questions, factor analysis was performed again for 15 questions to validate the domain structure. The number of factors was ment in adherence scores after 1 year and lipid values was analyzed by multiple regression analysis that included the following covariates: changes in scores, baseline adherence scores, and the above-mentioned selected background factors. The changes in the achieved lipid values were estimated as the adherence score increased by 1.
Results
Domain Structures of the Questionnaire
Of 6,229 patients who were starting or continuing pravastatin treatment and had registered for the study, those who withdrew their consent to participate in the study or violated entry criteria were excluded, and 5,871 patients were eligible for the analysis 15) . Of them, answers to the questionnaire were collected from 5,764 patients at baseline, and 5,025 patients after 1 year. A total of 5,792 patients, for whom answers to the questionnaire were collected either at baseline or after 1 year, were included in the analysis of adherence. The results of the questionnaire after 1 year were used to determine adherence scores, and those obtained at baseline were used in case the results 
Patients enrolled in the study: 
Relationship between Adherence Scores and Lipid Parameters
Of the patients eligible for adherence analysis, patients with missing LDL-C values by direct measurement (1,428 patients) and who did not provide complete answers to the questionnaire (12 patients) were excluded. As a result, 4,352 patients were included in the analysis to determine the relationship between adherence and values of lipid parameters ( Fig. 1) . Patient background characteristics are shown in Table 3 . Men accounted for 42.1%, and the mean age of the patients was 66 years. Those who had hypertension, diabetes, and 3 major risk factors comassumed to be 5 based on the same criteria as previously described. Questions were classified as one domain based on a cutoff point of 0.40 factor loading. In addition, Question 19, "Do you take your medicine according to instructions ?" was established as an independent domain. Six domains were named, "Awareness of health," "Preferable dietary behaviors," "Intake of high fat/cholesterol/sugar foods," "Smoking and drinking habits," "Exercise," and "Adherence to instructions for drug therapy" ( Table 1 ). The summary of scores is shown in Table 2 . It was found that Question 12 "How many days a week do you proactively take vitamins ?" had less consistency with other factors. In addition, patients could have various impressions from the question, for instance, supplements, vegetables, or fruits; therefore, this question was excluded from the questionnaire. In addition, there were 2 overlapping questions concerning use of a pedometer (frequency and number of steps), so the question asking for the number of steps was selected for Question 17, since it reflects the degree of exercise. Question 21, "Do you know what pravastatin is used for ?" was also excluded because it was likely to be affected by the outcomes of compliance guidance given to patients, which makes it difficult to assess patients' awareness of health. Table 5 ).
In the present study, questionnaire surveys composed of the same questions were conducted at baseline and after 1 year. The relationship between modifiprised 71.5%, 78.8%, and 84%, respectively, of the study population. Mean LDL-C, mean HDL-C, and median TG were 135.3 mg/dL, 57.6 mg/dL, and 122.0 mg/dL at baseline, and 119.4 mg/dL, 58.1 mg/ dL, and 116.0 mg/dL after 1 year, respectively. Table 4 and Fig. 2 show the results of single and multiple regression analyses performed to determine the relationship between adherence scores in each domain and the achieved LDL-C values. Single regression analysis showed a negative correlation between adherence scores and the achieved LDL-C (i.e. higher adherence scores are associated with lower achieved LDL value) in terms of "Preferable dietary behaviors" (regression coefficient −0.73, p = 0.0010), "Intake of high fat/cholesterol/sugar foods" (regression coefficient −0.73 and p = 0.0017) and "Adherence to instructions for drug therapy" (regression coefficient −7.45 and p＜0.0001). Multiple regression analysis also showed a significant correlation in terms of "Intake of high fat/ cholesterol/sugar foods" (regression coefficient −0.58 and p = 0.0105) and "Adherence to instructions for drug therapy" (regression coefficient −6.61 and p＜ 0.0001). No significant correlation was found for other domains, although the regression coefficients were negative (Fig. 2) .
On the other hand, when HDL-C values were used as a result variable, multiple regression analysis showed a significant correlation between HDL-C values and domains including "Awareness of health" (regression coefficient 0.26 and p = 0.0037), "Preferable dietary behaviors" (regression coefficient 0.75 and p＜0.0001), and "Exercise" (regression coefficient 0.73 and p = 0.0002), whereas no correlation was found for the domain of "Intake of high fat/cholesterol/sugar foods". Similar results were obtained when TG values were used a result variable: "Awareness of health" (regression coefficient −3.01 and p＜0.0001), "Prefer- Answer options for each question were evenly scored from 0 to 3 to indicate the worst to best adherence, and adherence scores were calculated by summing scores for each domain. § Adjustment factor: Adjustment was performed by factors that are associated with lipid values during each treatment [sex, age, baseline HDL-C, diabetes mellitus (including abnormal glucose tolerance)]. Regression coefficients indicate the change (difference) in the achieved LDL-C levels (mg/dL) as the score increased by 1. Adherence increases as the score increases. 
with better lipid control and cardiovascular outcomes. In addition, guidelines for the prevention of cardiovascular diseases in Western countries 17, 18) and the Japan Atherosclerosis Society guidelines 12) also emphasize that modification of lifestyle will lead to a decrease in lipid values and reduction in cardiovascular events. Recently, the concept of "adherence" concerning the patient's overall proactive behavior toward treatment prescribed by physicians has been established, and some evaluation studies have been conducted in western countries in various disease fields [19] [20] [21] . In this analysis, adherence to lipid management was assessed using our own questionnaire. Many of the studies assessing adherence also used original questionnaires [19] [20] [21] . We consider that each domain established from the questionnaire can fully reflect patients' attitudes to their treatment: for instance, "Awareness of health" reflects the extent to which patients are interested in their disease and attempts to enhance motivacation of lifestyle and changes in LDL-C values after 1 year was also analyzed. As a result, LDL-C values were significantly lower in patients who improved the adherence score in the "Awareness of health" domain compared with those with a decreased score in the domain. Moreover, LDL-C values were higher in patients with worsened adherence scores in the "Adherence to instructions for drug therapy" domain compared with others. For other domains, no significant correlation was found between changes in adherence scores and LDL-C values during treatment ( Table 6 ).
Discussion
Many interventional and epidemiological studies have shown that not only drug therapy, but also improvements in diet, smoking, alcohol consumption, exercise, and adherence to drug therapy are associated Answer options for each question were evenly scored from 0 to 3 to indicate the worst to best adherence, and adherence scores were calculated by summing scores for each domain. Adjustment factor: Adjustment was performed by factors that are associated with lipid values during each treatment (HDL-C: sex, baseline LDL-C; TG: sex, age, baseline HDL-C).
Regression coefficients indicate the change (difference) in the achieved HDL-C, TG levels (mg/dL) as the score increased by 1. Adherence increases as the score increases. "Intake of high fat/cholesterol/sugar foods." Similarly, TG values were lower in patients with high adherence scores. Previous epidemiological studies showed that moderate exercise can lead to an increase in HDL-C but not a decrease in TC and LDL-C values 24, 25) , and the results of the present study were similar to these findings. Although a favorable effect of exercise on lipid control has been reported in some interventional studies 26, 27) , the effect of proactive exercise on LDL-C seems limited according to the results of the present study.
Whereas cessation of smoking and alcohol consumption does not affect LDL-C, it was shown to be effective in the control of TG. Moreover, in contrast to TG, HDL-C is lower in patients with high adherence scores for cessation of smoking and alcohol consumption. This may be associated with the findings of a previous report showing that HDL-C tends to be low in smokers and high in individuals with an alcohol habit 28) . The results of the present study showed that, even under treatment with statins, modification of the entire lifestyle including not only dietary habits but also awareness of health will lead to improvements in LDL-C as well as HDL-C and TG levels. Although the impact on the cardiovascular outcome was not evaluated in this study, it is well known that improvements in lipid parameters will lead to the prevention of cardiovascular events 12, 18, 29) . The present study has some limitations, the most important being is that the target population in this study was limited to those who were taking pravastatin at the initiation of the study. Therefore, the results of this study should be interpreted carefully, considering that indirect effects of pravastatin treatment might be included in the findings. Another limitation is that LDL-C values obtained by direct measuring methods were used for the analysis. The study protocol did not specify whether the Friedewald calculation or direct measurement should be performed to obtain LDL-C values. Although a strong correlation was demonstrated between these values as reported previously 30) , they were not integrated into the present analysis since they were obtained based on a different concept. Consequently, the number of patients eligible for this analysis decreased, but there was still a sufficient number to provide adequate study power, and we consider that there should be no major influence on the interpretation of the analysis. Furthermore, it is well known that LDL-C values obtained by a direct method show different values according to the measuring kit 31) . In this study, there was no restriction on the brand of measurement kit in the protocol, which may attenuate the sensitivity of the analysis. Another tion for treatment; "Preferable dietary behaviors" reflects whether patients attempt to eat healthy foods such as vegetables, fruits, and fish while reducing total calories on a daily basis; "Intake of high fat/cholesterol/sugar foods" reflects whether patients attempt not to eat food containing animal fat (butter, whipped cream, lard, etc.), high cholesterol food, and carbohydrates.
Multiple regression analysis on the relationship between adherence scores of each domain and the achieved LDL-C values showed that higher adherence scores for "Intake of high fat/cholesterol/sugar foods" and "Adherence to instructions for drug therapy" are associated with lower achieved LDL-C values. This means that patients who reported that their intake of food containing animal fat, high-cholesterol food (egg yolks, liver, etc.) and sweets is low, and adherence to taking drugs is high had lower LDL-C values even under treatment with pravastatin. Assuming that linearity exists between adherence scores and LDL-C, in terms of "Intake of high fat/cholesterol/sugar foods," an increase in adherence score by 1 is associated with a lower LDL-C value by 0.6 mg/dL. Since adherence scores for "Intake of high fat/cholesterol/sugar foods" range between 0 and 9, the LDL-C value in patients with the best adherence should be 5.4 mg/dL lower than that of patients with the worst adherence. These results are consistent with previous findings of individual epidemiological data, which demonstrated that foods containing high cholesterol, fat and sugar were associated with high LDL-C 22, 23) . Moreover, as for dosing compliance, patients who took ≥ 90%, 70-80%, 50-69%, ＜50%, and 0% of the prescribed drugs were given 3, 2.25, 1.50, 0.75, and 0 as adherence scores, which means that if patients who usually forget to take their medication 1-2 times a week always took their medication, LDL-C could be reduced by approximately 6.6 mg/ dL. This indicates that establishing appropriate methods to ensure that drugs are taken is important, because about 53% and 15% of the patients reported "carelessly forget to take medicine" and "due to convenience of working or going out" as answers to the questionnaire in the present study. A significant correlation between LDL-C values and "Preferable dietary behaviors" was shown in single regression analysis, but not multiple regression analysis, and no association was observed for "Awareness of health," "Smoking and drinking habits," and "Exercise."
Relationships between HDL-C and TG values and adherence scores were also analyzed. HDL-C values were significantly higher in patients with high adherence scores in all lifestyle-related domains except important limitation is that the findings of this analysis were generated based on the patients' self-reported data. We did not assess the contents of the diet, exercise, and amount of residual drugs directly; therefore, the answer to each question depended on the patients' impressions. The short follow-up (1 year) was also a limitation. Regarding "Intake of high fat/cholesterol/ sugar foods" domain, "high sugar foods" might be separated from "high fat/cholesterol foods". When we generated the domains, we intended all high sugar foods from Q15, "How many days a week do you eat sweets ?", but the responder might assume this to mean cakes or other western sweets. The names of the adherence domains were decided subjectively according to the content of questions contained in each domain, and we do not intend to exclude the use of other terms which are more appropriate, if any.
Conclusion
In conclusion, the results of the present study showed that, in patients who have high awareness of their health and a positive attitude (adherence) toward lipid-lowering treatment, including diet, exercise, smoking and drinking, and high adherence to drug therapy there is a relationship with favorable overall lipid control even in patients under treatment with pravastatin.
